News Coverage

Contessa Partners With Memorial Hermann Health System To Deliver Home-Based, Hospital-Level Care

Home Care Health News, June 26, 2022 Contessa Health, an Amedisys Inc. (Nasdaq: AMED) company, has teamed up with Memorial Hermann Health System to provide home-based care services to its patients. Specifically, the partnership will allow Memorial Hermann to deliver acute hospital care, post-hospitalization skilled nursing care and palliative care services in the home setting. This new offering will increase accessibility for the organization’s patients, according to Dr. David Callender, president and CEO of Memorial Hermann. Click here to read the full article.

Read More

Amedisys Goes Full-Speed Ahead on New JV Strategy

Hospice News, June 16, 2022 Amedisys (NASDAQ: AMED) is fired up for more hospital joint ventures, a new area of focus for the Baton Rouge, La.-based home health and hospice provider. Driving this renewed interest is the company’s June 2021 purchase of Tennessee-based Contessa Health for $250 million. While Amedisys had a few JVs before that transaction, Contessa came with a fleshed-out model and an established pipeline for those arrangements. Click here to read the full article.

Read More

Contessa Health CEO: Managed Care Strategy Will Separate the ‘Haves and the Have Nots’

Home Health Care News, June 7, 2022 The ability to deliver higher-acuity care in the home is now table stakes. That’s especially true for health plans and health systems following the introduction of the COVID-related Acute Hospital Care at Home Waiver by the U.S. Centers for Medicare & Medicaid Services (CMS) in November 2020. Eventually, though, the public health emergency is going to go away – with the waiver possibly ending not too long after. And for higher-acuity care in the home to truly catch on over the long run, stakeholders will need to beef up their managed care strategies,…

Read More

Contessa acquisition paying unexpected dividends to Amedisys

McKnight’s Home Care, June 7, 2022 Amedisys President and CEO Chris Gerard told investors Monday the company’s acquisition last year of hospital-at-home firm Contessa could soon result in some surprising partnerships with large hospital systems. “We think we are going to be announcing some broader-based joint ventures in the future that I would say were not part of our roadmap prior to the acquisition of Contessa,” Gerard said during investment bank William Blair’s 42nd Annual Growth Stock Conference. Click here to read the full article.

Read More

How the Amedisys-Contessa Roadmap Has Changed Since the Acquisition Last Year

Home Health Care News, June 6, 2022 When Amedisys Inc. (Nasdaq: AMED) purchased Contessa Health, it touted the acquisition as a future-facing move that would allow the company to care for patients across the continuum. The company’s leaders knew it would be a near-term drag, and some analysts and home health insiders scratched their heads. Still, Amedisys reiterated the opportunity it saw in purchasing a provider of high-acuity care services in the home. But almost a year out from the official transaction date, the company’s tune has changed. Now, its leaders are moving forward considering Contessa Health – and high-acuity…

Read More

The Good, the Bad and the Ugly: What Nursing Homes Should Consider When Diving into SNF-at-Home

Skilled Nursing News, May 23, 2022 Nursing home executives are increasingly exploring what it would take to start a SNF-at-home program, at a time when it has become apparent after the height of a global pandemic that patients would rather be cared for in the home when at all possible. For many skilled nursing providers it becomes part of a bigger strategy to get and stay ahead of the curve as the long-term care industry moves toward a value-based payment world. SNF-at-home can also have considerable benefits, including a better patient experience and lower costs. Click here to read the full article.

Read More

Amedisys Chairman Paul Kusserow: Contessa Health put us in a ‘whole new league’

Nashville Business Journal, May 16, 2022 Contessa Health for $250 million, the company said it planned to “invest meaningfully” in Contessa’s growth. Nearly one year later, Amedisys’ plan for Contessa remains aggressive. “We expect this to be the future,” Amedisys Chairman and former CEO Paul Kusserow said in an interview. “Contessa just put us in an entirely new league. Being able to take people that would normally have to be in a hospital, bring them home and take care of them at home at about half the cost, particularly after Covid, it’s amazing. That’s where we want to go. We can…

Read More

High-Acuity Care Opportunities, Workforce Shortages Guide Amedisys’ M&A, JV Strategies

Home Health Care News, April 18, 2022 As a company, Amedisys delivers a number of offerings, including home health, hospice, personal care and high-acuity care services. The company’s footprint includes 350 care centers in 34 states and the District of Columbia, with an average daily census of about 74,000 patients. Leaning into those opportunities also means zeroing in on the JV relationships that Contessa has built, according to Novak. Click here to read the full article.

Read More

Hospital-at-home makes inroads in rural America

McKnights Home Care, April 4, 2022 Blessing Health System in rural Quincy, IL, is a guinea pig of sorts for hospital-at-home in the heartland. In late February, the 300-bed hospital in the small Mississippi River community became part of the Rural Home Hospital Model. The three-year pilot aims to provide insights on how hospital-at-home can be streamlined and scaled to meet the needs of rural patients. “We believe that rural health systems are uniquely positioned to reach critical mass with the hospital at home care model,” Contessa CEO Travis Messina said. Click here to read the full article.

Read More

Top 25 Innovators – 2022

Modern Healthcare, April 2, 2022 There’s no shortage of innovation in healthcare. Never has been. And that’s certainly been the case these past two years. Doing business as usual during a global pandemic wasn’t an option because lives were at stake. It required new products, new processes, new technologies and new thinking. As you’ll see by reading the profiles, transformation is alive and well in healthcare. Click here to read the full article.

Read More